MEOBF
Price
$1.73
Change
+$0.70 (+67.96%)
Updated
Dec 19 closing price
59 days until earnings call
SPHDF
Price
$9.42
Change
-$2.28 (-19.49%)
Updated
Dec 3 closing price
Ad is loading...

MEOBF vs SPHDF

Header iconMEOBF vs SPHDF Comparison
Open Charts MEOBF vs SPHDFBanner chart's image
Mesoblast
Price$1.73
Change+$0.70 (+67.96%)
Volume$1M
CapitalizationN/A
Santhera Pharmaceuticals Holdings
Price$9.42
Change-$2.28 (-19.49%)
Volume$1K
CapitalizationN/A
MEOBF vs SPHDF Comparison Chart
Loading...
MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MEOBF vs. SPHDF commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEOBF is a Hold and SPHDF is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (MEOBF: $1.73 vs. SPHDF: $9.42)
Brand notoriety: MEOBF and SPHDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MEOBF: 2310% vs. SPHDF: 197%
Market capitalization -- MEOBF: $1.71B vs. SPHDF: $141.87M
MEOBF [@Biotechnology] is valued at $1.71B. SPHDF’s [@Biotechnology] market capitalization is $141.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEOBF’s FA Score shows that 0 FA rating(s) are green whileSPHDF’s FA Score has 0 green FA rating(s).

  • MEOBF’s FA Score: 0 green, 5 red.
  • SPHDF’s FA Score: 0 green, 5 red.
According to our system of comparison, both MEOBF and SPHDF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEOBF’s TA Score shows that 5 TA indicator(s) are bullish while SPHDF’s TA Score has 1 bullish TA indicator(s).

  • MEOBF’s TA Score: 5 bullish, 2 bearish.
  • SPHDF’s TA Score: 1 bullish, 2 bearish.
According to our system of comparison, MEOBF is a better buy in the short-term than SPHDF.

Price Growth

MEOBF (@Biotechnology) experienced а +67.96% price change this week, while SPHDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

MEOBF is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MEOBF($1.71B) has a higher market cap than SPHDF($142M). MEOBF YTD gains are higher at: 937.792 vs. SPHDF (-19.487).
MEOBFSPHDFMEOBF / SPHDF
Capitalization1.71B142M1,207%
EBITDA-62.82MN/A-
Gain YTD937.792-19.487-4,812%
P/E RatioN/A1.46-
Revenue5.9MN/A-
Total Cash62.6MN/A-
Total Debt119MN/A-
FUNDAMENTALS RATINGS
MEOBF vs SPHDF: Fundamental Ratings
MEOBF
SPHDF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
3484
P/E GROWTH RATING
1..100
5854
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SPHDF's Valuation (50) in the null industry is somewhat better than the same rating for MEOBF (89). This means that SPHDF’s stock grew somewhat faster than MEOBF’s over the last 12 months.

MEOBF's Profit vs Risk Rating (82) in the null industry is in the same range as SPHDF (100). This means that MEOBF’s stock grew similarly to SPHDF’s over the last 12 months.

MEOBF's SMR Rating (95) in the null industry is in the same range as SPHDF (100). This means that MEOBF’s stock grew similarly to SPHDF’s over the last 12 months.

MEOBF's Price Growth Rating (34) in the null industry is somewhat better than the same rating for SPHDF (84). This means that MEOBF’s stock grew somewhat faster than SPHDF’s over the last 12 months.

SPHDF's P/E Growth Rating (54) in the null industry is in the same range as MEOBF (58). This means that SPHDF’s stock grew similarly to MEOBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEOBFSPHDF
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
56%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
40%
MACD
ODDS (%)
Bullish Trend 3 days ago
62%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
11%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
54%
Bearish Trend 3 days ago
52%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
61%
N/A
View a ticker or compare two or three
Ad is loading...
MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERI2.300.12
+5.50%
Veritone
TME11.950.16
+1.36%
Tencent Music Entertainment Group
COGT7.840.04
+0.51%
Cogent Biosciences
KFY66.560.33
+0.50%
Korn Ferry
XIN2.27-0.23
-9.20%
Xinyuan Real Estate Co Ltd

MEOBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEOBF has been loosely correlated with SPHDF. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MEOBF jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEOBF
1D Price
Change %
MEOBF100%
N/A
SPHDF - MEOBF
50%
Loosely correlated
N/A
AVTX - MEOBF
46%
Loosely correlated
-1.87%
COGT - MEOBF
39%
Loosely correlated
+0.51%
MESO - MEOBF
26%
Poorly correlated
-12.71%
KROS - MEOBF
26%
Poorly correlated
+0.65%
More

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with TRML. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then TRML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
TRML - SPHDF
78%
Closely correlated
+1.52%
COGT - SPHDF
63%
Loosely correlated
+0.51%
MEOBF - SPHDF
50%
Loosely correlated
N/A
KROS - SPHDF
38%
Loosely correlated
+0.65%
CYTOF - SPHDF
35%
Loosely correlated
-60.07%
More